{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:31:09Z","timestamp":1770071469753,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ygyno.2005.08.036","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T18:22:59Z","timestamp":1128450179000},"page":"344-348","source":"Crossref","is-referenced-by-count":66,"title":["Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"100","author":[{"given":"Scott M.","family":"Eisenkop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick M.","family":"Spirtos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chien Michael","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.08.036_bib1","first-page":"131","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian cancer","volume":"42","author":"Griffiths","year":"1978","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2005.08.036_bib2","first-page":"413","article-title":"Primary cytoreductive surgery for ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib4","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.08.036_bib5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","article-title":"Randomized trial of cyclophosphamide plus cisplatin with or without doxirubicin in ovarian carcinoma: a gynecologic oncology group study","volume":"7","author":"Omura","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with ovarian cancer. A prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0090-8258(90)90277-R","article-title":"Primary surgical therapy for ovarian cancer: how much and when","volume":"40","author":"Potter","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/gyno.2001.6375","article-title":"The effect of bowel resection on survival in advanced epithelial ovarian cancer","volume":"83","author":"Jaeger","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-8258(03)00342-1","article-title":"Future directions in the surgical management of ovarian cancer","volume":"92","author":"Berman","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0090-8258(90)90415-H","article-title":"Electrosurgical debulking of ovarian cancer: a new technique using the Argon Beam Coagulator","volume":"39","author":"Brand","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9378(92)91345-B","article-title":"The cavitronal ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer","volume":"166","author":"Rose","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0090-8258(89)90074-7","article-title":"Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer","volume":"35","author":"Montz","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/gyno.1995.1123","article-title":"Loop electrosurgical excision procedure for intensified cytoreduction surgery of ovarian cancer","volume":"57","author":"Fanning","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib17","first-page":"879","article-title":"Modified posterior exenteration for ovarian cancer","volume":"78","author":"Eisenkop","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/gyno.1995.1061","article-title":"Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy","volume":"56","author":"Spirtos","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/gyno.2001.6232","article-title":"The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib20","first-page":"695","article-title":"Treatment of external pancreatic fistulas with somatostatin","volume":"55","author":"Lansen","year":"1989","journal-title":"Am. Surg."},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2005.08.036_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000201410","article-title":"Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders","volume":"57","author":"Freiss","year":"1996","journal-title":"Digestion"},{"key":"10.1016\/j.ygyno.2005.08.036_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0039-6060(05)80225-9","article-title":"Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized trial","volume":"117","author":"Montorsi","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.ygyno.2005.08.036_bib23","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.270.15.1826","article-title":"Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ygyno.2005.08.036_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1096-8652(200009)65:1<25::AID-AJH4>3.0.CO;2-8","article-title":"Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist","volume":"65","author":"Brigden","year":"2000","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib25","first-page":"586","article-title":"The current status of vaccination and antibiotic prophylaxis in splenectomy","volume":"68","author":"Funk","year":"1997","journal-title":"Chirung"},{"key":"10.1016\/j.ygyno.2005.08.036_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jcp.55.6.472","article-title":"A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland","volume":"55","author":"Kyaw","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.5842","article-title":"Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?","volume":"78","author":"Naik","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/gyno.1997.4839","article-title":"Does debulking surgery improve survival in biologically aggressive ovarian cancer","volume":"67","author":"Le","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/gyno.2001.6313","article-title":"Procedures required to accomplish complete cytoreduction for ovarian cancer. Is there a correlation with \u201cbiological aggressiveness\u201d and survival?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.2000.5800","article-title":"Splenectomy and surgical cytoreduction for ovarian cancer","volume":"77","author":"Chen","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-8258(89)90068-1","article-title":"Splenectomy during primary cytoreductive surgery for ovarian cancer","volume":"35","author":"Sonnendecker","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib32","first-page":"19","article-title":"Splenectomy in cytoreductive surgery in ovarian cancer","volume":"45","author":"Scarabelli","year":"1993","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/gyno.1998.5141","article-title":"Splenectomy in recurrent epithelial ovarian cancer","volume":"72","author":"Gemignani","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/gyno.1993.1059","article-title":"Solitary recurrent metastasis of epithelial ovarian cancer in the spleen","volume":"48","author":"Farias-Eisner","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1048-891X.2004.014940.x","article-title":"The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer","volume":"14","author":"Ayhan","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2005.08.036_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.036_bib37","first-page":"564","article-title":"Contraindications and complications in vaccinations","volume":"137","author":"Sitzman","year":"1987","journal-title":"Wien Med. Wochenschr."},{"key":"10.1016\/j.ygyno.2005.08.036_bib38","series-title":"Gynecologic cancer surgery","article-title":"Surgery for ovarian neoplasia","author":"Morrow","year":"1996"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580500764X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580500764X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T02:50:52Z","timestamp":1553655052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082580500764X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S009082580500764X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.08.036","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}